Winnie Prosise

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Winnie Prosise is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, rapid evolution, and checkpoint inhibitor therapy.

Publications per year

2022–2022

Publications

Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical Candidates

Mihirbaran Mandal, Li Xiao, Weidong Pan et al. · Journal of Medicinal Chemistry · 2022 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy

Lars Guelen, Thierry Fischmann, Jerelyn Wong et al. · Journal for ImmunoTherapy of Cancer · 2022 · 16 citations · Full text

Medicine, Oncology, Pharmacology +15

1–2 of 2